Legacy Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$473K	Hold	800	–	–	0.16%	110
2021 Q4	$534K	Hold	800	–	–	0.17%	101
2021 Q3	$457K	Sell	800 -125	-14%	-$68.6K	0.17%	104
2021 Q2	$467K	Buy	925 +205	+28%	+$96.7K	0.17%	104
2021 Q1	$329K	Buy	720 +70	+11%	+$33.4K	0.12%	115
2020 Q4	$303K	Hold	650	–	–	0.12%	117
2020 Q3	$287K	Hold	650	–	–	0.12%	111
2020 Q2	$236K	Buy	+650	New	+$218K	0.1%	127
2020 Q1	–	Sell	-650	Closed	-$211K	–	156
2019 Q4	$211K	Buy	+650	New	+$197K	0.09%	152

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legacy Capital Partners's TMO Position: Q1 2022 in Review

Legacy Capital Partners held its Thermo Fisher Scientific (TMO) position steady in Q1 2022 at 800 shares worth $473K. The position accounts for 0.16% of the portfolio, ranked #110.

Legacy Capital Partners first reported a position in TMO in Q4 2019 and has held it in 9 quarters since. The position peaked at $534K in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Legacy Capital Partners held 800 shares of Thermo Fisher Scientific worth $473K as of Q1 2022.
Legacy Capital Partners left its Thermo Fisher Scientific share count unchanged in Q1 2022.
Thermo Fisher Scientific made up 0.16% of Legacy Capital Partners's portfolio in Q1 2022, its #110 holding.
Legacy Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 9 quarters since.
Legacy Capital Partners's Thermo Fisher Scientific position peaked at $534K in Q4 2021.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.